Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mesenchymal Stem Cells

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

Bone Marrow Transplantation volume 33, pages 597–604 (2004)Cite this article

Summary:

Bone marrow-derived mesenchymal stem cells (MSCs) are known to interact with hematopoietic stem cells (HSCs) and immune cells, and represent potential cellular therapy to enhance allogeneic hematopoietic engraftment and prevent graft-versus-host disease (GVHD). We investigated the role of human MSCs in NOD-SCID mice repopulation by unrelated human hematopoietic cells and studied the immune interactions between human MSCs and unrelated donor blood cells in vitro. When hematopoietic stem cell numbers were limited, human engraftment of NOD-SCID mice was observed only after coinfusion of unrelated human MSCs, but not with coinfusion of mouse mesenchymal cell line. Unrelated human MSCs did not elicit T-cell activation in vitro and suppressed T-cell activation by Tuberculin and unrelated allogeneic lymphocytes in a dose-dependent manner. Cell-free MSC culture supernatant, mouse stromal cells and human dermal fibroblasts did not elicit this effect. These preclinical data suggest that unrelated, human bone marrow-derived, culture-expanded MSCs may improve the outcome of allogeneic transplantation by promoting hematopoietic engraftment and limiting GVHD and their therapeutic potential should be tested in clinic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Koç O, Lazarus H . Mesenchymal stem cells heading to the clinic. Bone Marrow Transplant 2001; 27: 235–239.

    Google Scholar 

  2. Bianco P, Constantini M, Dearden L, Bonucci E . Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 1988; 68: 401–411.

    CAS  Google Scholar 

  3. Haynesworth S, Goshima J, Goldberg V, Caplan A . Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81–88.

    CAS  Google Scholar 

  4. Pittinger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.

    Google Scholar 

  5. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–49.

    CAS  Google Scholar 

  6. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615–2625.

    CAS  Google Scholar 

  7. Toksoz D, Zsebo K, Smith K et al. Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992; 89: 7350–7354.

    CAS  Google Scholar 

  8. Clark B, Keating A . Biology of bone marrow stroma. Ann NY Acad Sci 1995; 770: 70–88.

    CAS  Google Scholar 

  9. Majumdar M, Thiede M, Haynesworth S et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2001; 9: 841–848.

    Google Scholar 

  10. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 186–192.

    Google Scholar 

  11. LeBlanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20.

    CAS  Google Scholar 

  12. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–397.

    CAS  Google Scholar 

  13. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838.

    CAS  Google Scholar 

  14. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 72: 1653–1655.

    Google Scholar 

  15. Caplan A . Mesenchymal stem cells. J Orthop Res 1991; 9: 641–650.

    CAS  Google Scholar 

  16. Haynesworth S, Baber M, Caplan A . Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69–80.

    CAS  Google Scholar 

  17. Koç O, Gerson S, Cooper B et al. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high dose chemotherapy. J Clin Oncol 2000; 18: 307–316.

    Google Scholar 

  18. Koç O, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215–222.

    Google Scholar 

  19. Schafer I, Pandy M, Ferguson R, Davis B . Comparative observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: growth kinetics, packing density at confluence and surface morphology. Mech Ageing Dev 1985; 31: 275–293.

    CAS  Google Scholar 

  20. Dennis J, Merriam A, Awadallah A et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Min Res 1999; 14: 700.

    CAS  Google Scholar 

  21. Tary-Lehmann M, Hricik D, Justice A et al. Enzyme-linked immunosorbent assay spot detection of interferon and interleukin-5 producing cells as a predictive marker for renal allograft failure. Transplantation 1998; 66: 219–224.

    CAS  Google Scholar 

  22. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    CAS  Google Scholar 

  23. Anklesaria P, Kase K, Glowacki J et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 1987: 7681–7685.

    Google Scholar 

  24. Nolta J, Hanley M, Kohn D . Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 1994; 83: 3041–3051.

    CAS  Google Scholar 

  25. Almeida-Porada G, Porada C, Tran N, Zanjani E . Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620–3627.

    CAS  Google Scholar 

  26. Noort WA, Kruisselbrink AB, Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870–878.

    Google Scholar 

  27. Angelopoulou M, Novelli E, Grove J et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003; 31: 413–420.

    CAS  Google Scholar 

  28. Lee K, Gerson SL, Maitra B, Koc ON . G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU. J Hematother Stem Cell Res 2001; 10: 691–701.

    CAS  Google Scholar 

  29. Sandmaier B, Strob R, Kniley J et al. Evidence of allogeneic stromal engraftment in bone marrow using canine mesenchymal stem cells. Blood 1998; 92: 116a.

    Google Scholar 

  30. Devine S, Bartholomew A, Mahmud N et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244–255.

    CAS  Google Scholar 

  31. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729.

    CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Magdalena Tary-Lehmann for assistance with the Elispot assay, Stem Cell, Athymic Animal, Flow Cytometry and Radiation Resources Core Facilities of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). This work was supported by NIH, R01HL62360 (PI: ON Koç).

Author information

Authors and Affiliations

  1. Comprehensive Cancer Center, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, OH, USA

    B Maitra, E Szekely, K Gjini, M J Laughlin & O N Koç

  2. Division of Hematology/Oncology, Department of Medicine, Cleveland, OH, USA

    M J Laughlin & O N Koç

  3. Department of Biology, Skeletal Research Center, Case Western Reserve University, Cleveland, OH, USA

    J Dennis & S E Haynesworth

Authors
  1. B Maitra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Szekely
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Gjini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M J Laughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Dennis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S E Haynesworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O N Koç
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O N Koç.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maitra, B., Szekely, E., Gjini, K. et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33, 597–604 (2004). https://doi.org/10.1038/sj.bmt.1704400

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704400

Keywords

This article is cited by

Search

Advanced search

Quick links